Literature DB >> 26192398

Characteristics and Outcomes of Eligible Nonenrolled Patients in a Mechanical Ventilation Trial of Acute Respiratory Distress Syndrome.

Yaseen M Arabi1, Deborah J Cook2,3, Qi Zhou3, Orla Smith4, Lori Hand3, Alexis F Turgeon5,6, Andrea Matte7, Sangeeta Mehta8,9, Russell Graham10, Kristin Brierley11, Neill K J Adhikari8,12, Maureen O Meade2,3, Niall D Ferguson7,13,14,15,16.   

Abstract

RATIONALE: Patients eligible for randomized controlled trials may not be enrolled for various reasons. Nonenrollment may affect study generalizability and lengthen the time required for trial completion.
OBJECTIVES: To describe characteristics and outcomes of eligible nonenrolled (ENE) patients in a multicenter trial of mechanical ventilation strategies.
METHODS: Within the OSCILLATE trial of high-frequency oscillation (HFO) versus conventional ventilation (CV) in adults with adult respiratory distress syndrome, and with approval from research ethics boards, we collected a minimal dataset on patients who satisfied eligibility criteria but were not enrolled. We categorized ENE patients as ENE-HFO and ENE-CV based on receipt of HFO at any time. We used multivariable logistic regression to assess the association between ENE status and mortality.
MEASUREMENTS AND MAIN RESULTS: A total of 548 patients were randomized, and 546 were ENE. The most common reasons for ENE were no consent (42%), physician refusal (24%), missed randomization window (15%), and current HFO use (14%). Compared with randomized patients in respective arms of the trial, ENE-HFO patients were younger and had worse lung injury, whereas ENE-CV patients had lower illness severity. ENE status was independently associated with mortality (adjusted odds ratio, 1.39; 95% confidence interval, 1.06-1.84; P = 0.02), with no significant interaction with ventilation treatment group.
CONCLUSIONS: Nonenrollment was common, with approximately one ENE patient for every randomized patient. Our study suggests that enrollment in trials of mechanical ventilation may be associated with improved outcomes compared with standard care and highlights the need for prospective tracking and transparent reporting of ENE patients as part of trial management.

Entities:  

Keywords:  high-frequency ventilation; mechanical ventilation; mortality; patient recruitment; randomized controlled trial

Mesh:

Year:  2015        PMID: 26192398     DOI: 10.1164/rccm.201501-0172OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

1.  Effect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Therapy on Liberation From Respiratory Support in Acutely Ill Children Admitted to Pediatric Critical Care Units: A Randomized Clinical Trial.

Authors:  Padmanabhan Ramnarayan; Alvin Richards-Belle; Laura Drikite; Michelle Saull; Izabella Orzechowska; Robert Darnell; Zia Sadique; Julie Lester; Kevin P Morris; Lyvonne N Tume; Peter J Davis; Mark J Peters; Richard G Feltbower; Richard Grieve; Karen Thomas; Paul R Mouncey; David A Harrison; Kathryn M Rowan
Journal:  JAMA       Date:  2022-07-12       Impact factor: 157.335

2.  Effect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Following Extubation on Liberation From Respiratory Support in Critically Ill Children: A Randomized Clinical Trial.

Authors:  Padmanabhan Ramnarayan; Alvin Richards-Belle; Laura Drikite; Michelle Saull; Izabella Orzechowska; Robert Darnell; Zia Sadique; Julie Lester; Kevin P Morris; Lyvonne N Tume; Peter J Davis; Mark J Peters; Richard G Feltbower; Richard Grieve; Karen Thomas; Paul R Mouncey; David A Harrison; Kathryn M Rowan
Journal:  JAMA       Date:  2022-04-26       Impact factor: 157.335

3.  Development and Content Validation of a Multidisciplinary Standardized Management Pathway for Hypoxemic Respiratory Failure and Acute Respiratory Distress Syndrome.

Authors:  Ken Kuljit S Parhar; Karolina Zjadewicz; Gwen E Knight; Andrea Soo; Jamie M Boyd; Danny J Zuege; Daniel J Niven; Christopher J Doig; Henry T Stelfox
Journal:  Crit Care Explor       Date:  2021-05-17

4.  Low Plasma Levels of Adiponectin Do Not Explain Acute Respiratory Distress Syndrome Risk: a Prospective Cohort Study of Patients with Severe Sepsis.

Authors:  Jessica A Palakshappa; Brian J Anderson; John P Reilly; Michael G S Shashaty; Ryo Ueno; Qufei Wu; Caroline A G Ittner; Anna Tommasini; Thomas G Dunn; Dudley Charles; Altaf Kazi; Jason D Christie; Nuala J Meyer
Journal:  Crit Care       Date:  2016-03-16       Impact factor: 9.097

Review 5.  Identification of tools used to assess the external validity of randomized controlled trials in reviews: a systematic review of measurement properties.

Authors:  Andres Jung; Julia Balzer; Tobias Braun; Kerstin Luedtke
Journal:  BMC Med Res Methodol       Date:  2022-04-06       Impact factor: 4.615

6.  Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry.

Authors:  Colin H Holtze; Elizabeth A Freiheit; Susan L Limb; John L Stauffer; Karina Raimundo; Wayne T Pan; Kevin R Flaherty; Hyun J Kim
Journal:  Respir Res       Date:  2020-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.